JUN 24, 2021 8:00 AM PDT

Should We Rethink COVID Vaccine Recipes?

WRITTEN BY: Tara Fernandez

In a study reported in the journal Cell, immunologists provide evidence for an Achilles’ heel in current COVID-19 vaccines: they don’t harness the full potential of the immune system. Commercially-available COVID vaccines work by triggering B cells, immune cells responsible for the generation of virus-specific antibodies.

However, vaccines capable of simultaneously activating T cells have the potential to bolster immunity against SARS-CoV-2 and critically, the rapidly emerging viral variants. Now, researchers have identified a panel of SARS-CoV-2 viral peptides capable of eliciting powerful and potentially life-saving T cell-mediated immune responses.

According to Boston University’s Mohsan Saeed, one of the study authors, based on this new data, “companies should reevaluate their vaccine designs.”

Saeed teamed up with computational geneticists to identify SARS-CoV-2 fragments capable of mounting a robust protective T cell response. Cells in the body infected with viruses “chop up” viral proteins into tiny fragments that are presented on the surface of cells to alert T cells to the pathogenic intruder. Once the alarm is raised, T cells launch an all-out attack on infected cells, eliminating them and halting the progression of the infection. In the case of COVID-19, the stronger these T cell responses are, the less likely it is that patients will go on to develop severe, life-threatening symptoms.

Importantly, once T cells are primed, they “remember” the coronavirus’ fragments, setting off a much stronger and faster immune attack the next time it encounters the virus or its variants. This is a particularly advantageous feature in the context of COVID infections, as the researchers say that these are often associated with a lag in immune cell recruitment.

“This virus wants to go undetected by the immune system for as long as possible,” Saeed says. “Once it’s noticed by the immune system, it’s going to be eliminated, and it doesn’t want that.”

Saeed and colleagues say the protein fragments the team discovered could be used for novel vaccine recipes that are capable of shielding against the ever-growing number of coronavirus variants. Such a variant-resistant COVID vaccine would be a powerful weapon in our fight against the virus.

 

Sources: Cell, Boston University.


 

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
MAY 24, 2021
Cell & Molecular Biology
Animal Trial of Asthma Vaccine Has Positive Results
MAY 24, 2021
Animal Trial of Asthma Vaccine Has Positive Results
Asthma is thought to affect 340 million people. A type of asthma that happens when allergens like dust mites are inhaled ...
JUN 08, 2021
Immunology
Is the Pfizer-BioNtech Vaccine Variant-Resistant?
JUN 08, 2021
Is the Pfizer-BioNtech Vaccine Variant-Resistant?
Genetic variants of SARS-CoV-2 have emerged over the course of the pandemic, threatening public health efforts to limit ...
JUL 01, 2021
Immunology
Simple Dietary Changes Could Help Ease Skin and Joint Inflammation
JUL 01, 2021
Simple Dietary Changes Could Help Ease Skin and Joint Inflammation
Eating too much sugar and fat can have a dramatic impact on the gut microflora, which in turn can flare up inflammatory ...
JUL 06, 2021
Immunology
New Nanotechnology Delivers RNA Drugs Only to "Bad" Immune Cells
JUL 06, 2021
New Nanotechnology Delivers RNA Drugs Only to "Bad" Immune Cells
Inflammatory conditions are linked to an overactive immune system, and resolving them therapeutically often involves cal ...
AUG 31, 2021
Immunology
Convalescent Plasma Therapy for COVID-19 Doesn't Work
AUG 31, 2021
Convalescent Plasma Therapy for COVID-19 Doesn't Work
After encountering an infectious agent, the immune system begins churning out antibodies—Y-shaped warriors that ne ...
SEP 09, 2021
Cancer
Can a Mole Fight Melanoma?
SEP 09, 2021
Can a Mole Fight Melanoma?
About 30% of melanoma cases arise from an existing nevus.  More commonly known as moles, Nevi are skin growths that ...
Loading Comments...